Letters
Breakthrough cancer pain
Morphine remains gold standard in breakthrough cancer pain
BMJ 2008; 337 doi: https://doi.org/10.1136/bmj.a3104 (Published 24 December 2008) Cite this as: BMJ 2008;337:a3104
- Vicente Ruiz-Garcia1,
- Eduardo Lopez-Briz1
- 1Home Hospitalisation Unit, HU La Fe, 46014 Valencia, Spain
- ruiz_vicgar{at}redcaspe.org
Although Davies and colleagues argue that little evidence supports the unlicensed use of oral morphine,1 morphine remains the gold standard in cancer pain. Licensed or unlicensed use is a transient status, especially in palliative care. Little evidence may support the use of oral …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £173 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£38 / $45 / €42 (excludes VAT)
You can download a PDF version for your personal record.